Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
9.74
-0.27 (-2.70%)
At close: Mar 19, 2026, 4:00 PM EDT
9.77
+0.03 (0.31%)
After-hours: Mar 19, 2026, 7:59 PM EDT
Novavax Employees
Novavax had 749 employees as of December 31, 2025. The number of employees decreased by 203 or -21.32% compared to the previous year.
Employees
749
Change (1Y)
-203
Growth (1Y)
-21.32%
Revenue / Employee
$1,499,972
Profits / Employee
$587,853
Market Cap
1.59B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Recursion Pharmaceuticals | 600 |
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Ocular Therapeutix | 325 |
| Zymeworks | 264 |
| Relay Therapeutics | 192 |
| Soleno Therapeutics | 182 |
NVAX News
- 9 days ago - Novavax, Inc. (NVAX) Presents at Leerink Global Healthcare Conference 2026 Transcript - Seeking Alpha
- 16 days ago - Novavax, Inc. (NVAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 20 days ago - What's Going On With Novavax Stock On Friday? - Benzinga
- 20 days ago - Novavax: The Bear Case Is Broken, But The Bull Case Needs More Proof - Seeking Alpha
- 21 days ago - Novavax to Participate in Upcoming Investor Conferences - PRNewsWire
- 21 days ago - Novavax, Inc. (NVAX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb - Benzinga
- 21 days ago - Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals - Reuters